Store

Home
Wuxi Biologics Co Ltd
Wuxi Apr 2021 483

483 Document: Wuxi Biologics Co Ltd, Apr 2, 2021

Jonathan W. Chapman, FDA Investigator

FDANews 483 Wuxi Biologics Co Ltd Apr 2 2021 top

Jonathan W. Chapman FDA Investigator

On Apr 02, 2021, the FDA inspected Wuxi Biologics Co Ltd's Wuxi site. Explore the inspectional observations.

Wuxi Biologics Co Ltd

483 Document

Issued: Apr 2, 2021

Details

Human DrugInspection
Wuxi / China
12 days

Available for Download - $199

[email protected]
+1 (650) 646-4996

About

About Us
Terms of Service
Privacy Policy
Support

GMP Resources

FDA Inspections DB

FDA Form 483 Database

Document Review

Related Apps

Quality Regulatory Intelligence

Redica Platform

Formerly FDAzilla, Redica is a data analytics platform built for the life sciences to improve product quality and reduce regulatory risk.

Clinical Trials Analytics

Clincosm

Marketplace connecting patients to clinical trials to accelerate patient recruitment is accelerating medicine

Productivity

CalendarCrush

App for calendar-driven people to account and bill for their time

Spectator Sports

BlitzSports

Score Clock App for youth sports parents asked to be time-keeper. This is the scorekeeping of the future.

Copyright © 2007 - 2024 Zymergi, Inc.